Related references
Note: Only part of the references are listed.The Kaposi's Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals
Yasaman Mortazavi et al.
VIRUSES-BASEL (2020)
KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions
Nader Kim El-Mallawany et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cancer incidence in older adults in selected regions of sub-Saharan Africa, 2008-2012
Sophie Pilleron et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
IP-10 is highly involved in HIV infection
Jie Lei et al.
CYTOKINE (2019)
Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis
Salum J. Lidenge et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
The Spectrum of Underlying Causes of latrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study
Can Baykal et al.
INDIAN JOURNAL OF DERMATOLOGY (2019)
B cells and their cytokine activities implications in human diseases
Simon Fillatreau
CLINICAL IMMUNOLOGY (2018)
Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia
Watson Mtonga et al.
CURRENT HIV RESEARCH (2018)
RNA-Seq of Kaposi's sarcoma reveals alterations in glucose and lipid metabolism
For Yue Tso et al.
PLOS PATHOGENS (2018)
Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada
Robert Dubrow et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2017)
Kaposi sarcoma herpesvirus pathogenesis
Giuseppe Mariggio et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
IL-5 in the plasma-cell-dominant Castleman disease: a nosological entity
Hans Raj Pahadiya et al.
OXFORD MEDICAL CASE REPORTS (2016)
Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration
Louise Giffin et al.
MBIO (2015)
Kaposi's sarcoma at the University Teaching Hospital, Lusaka, Zambia in the antiretroviral therapy era
Owen Ngalamika et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
What Lies Within: Coinfections and Immunity
Blossom Damania et al.
CELL HOST & MICROBE (2014)
New Onset of Kaposi Sarcoma in a Human Immunodeficiency Virus-1-Infected Homosexual Man, Despite Early Antiretroviral Treatment, Sustained Viral Suppression, and Immune Restoration
Amrei von Braun et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK
Emilio Letang et al.
AIDS (2013)
Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10/CXCR3 and SDF-1/CXCR4 axis produce IFN-γ in response to Bacille Calmette Guerin
Xiaoying Fu et al.
CLINICAL IMMUNOLOGY (2013)
Treatment Response and Mortality among Patients Starting Antiretroviral Therapy with and without Kaposi Sarcoma: A Cohort Study
Mhairi Maskew et al.
PLOS ONE (2013)
Higher Levels of Neutralizing Antibodies against KSHV in KS Patients Compared to Asymptomatic Individuals from Zambia
Pankaj Kuma et al.
PLOS ONE (2013)
Viral Interleukin-6: Role in Kaposi's Sarcoma-Associated Herpesvirus-Associated Malignancies
Shuhei Sakakibara et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
The emerging role of CXCL10 in cancer (Review)
Mingli Liu et al.
ONCOLOGY LETTERS (2011)
Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
Katie Wakeham et al.
INFECTIOUS AGENTS AND CANCER (2011)
CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas
Blanche Ka Ki Lo et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Kaposi's sarcoma in sub-Saharan Africa: a current perspective
A. Mosam et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
IL-6: from its discovery to clinical applications
Tadamitsu Kishimoto
INTERNATIONAL IMMUNOLOGY (2010)
Brain Tumor Immunotherapy with Type-1 Polarizing Strategies
Hideho Okada
CANCER VACCINES (2009)
IL-5-and eosinophil-mediated inflammation: from discovery to therapy
Taku Kouro et al.
INTERNATIONAL IMMUNOLOGY (2009)
The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells
Oliver Dienz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location:: An exploratory study
Rohit Upadhyay et al.
CLINICAL IMMUNOLOGY (2008)
Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model
Kai Mei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Classic Kaposi Sarcoma in the United States over the last two decades: A clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma
Kim M. Hiatt et al.
MODERN PATHOLOGY (2008)
The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10
Xiao-Ling Lu et al.
VACCINE (2008)
HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load
Toby Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
K. Kawada et al.
ONCOGENE (2007)
Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: Relevance for the development of human breast cancer
Dipak Datta et al.
CANCER RESEARCH (2006)
Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
V Martinez et al.
BRITISH JOURNAL OF CANCER (2006)
Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer
JB Reome et al.
CLINICAL IMMUNOLOGY (2004)
Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma
B Ensoli et al.
SEMINARS IN CANCER BIOLOGY (2000)
Share Paper
